Windtree Therapeutics, Inc. Profile Avatar - Palmy Investing

Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include ist…

Biotechnology
US, Warrington [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Windtree Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of WINT's Analysis
CIK: 946486 CUSIP: 97382D303 ISIN: US97382D4025 LEI: - UEI: -
Secondary Listings
WINT has no secondary listings inside our databases.